Related Experiment Video
Updated: Jun 17, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
Serious bacterial infection in recently immunized young febrile infants
Margaret Wolff1, Richard Bachur1
1From the Department of Medicine (MW, RB) and the Division of Emergency Medicine (RB), Children's Hospital Boston, Harvard Medical School, Boston, MA.
Insights
Febrile infants receiving immunizations have a lower risk of serious bacterial infection (SBI), especially within 24 hours. However, urinary tract infections (UTI) remain a risk, warranting urine testing in infants presenting shortly after vaccination.
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- Febrile infants without a clear source of infection require careful evaluation for serious bacterial infections (SBI).
- Recent immunizations can alter the clinical presentation and diagnostic considerations in febrile infants.
Purpose of the Study:
- To determine the prevalence of SBI in febrile infants aged 6-12 weeks who received immunizations within 72 hours.
- To compare SBI rates in infants with and without recent immunizations.
Main Methods:
- Retrospective medical record review of 1,978 febrile infants (age 6-12 weeks) presenting to a pediatric emergency department.
- Infants categorized into recent immunization (RI) and no recent immunization (NRI) groups based on vaccination within 72 hours prior to presentation.
- SBI defined by positive blood and/or urine cultures.
Main Results:
- Overall SBI prevalence was 6.6%.
- SBI prevalence was lower in infants with recent immunizations (2.8%) compared to those without (7.0%).
- Infants vaccinated within 24 hours had a significantly lower SBI prevalence (0.6%), with all identified SBIs being UTIs.
Conclusions:
- The risk of SBI is reduced in the 24 hours following infant immunizations.
- Urinary tract infections (UTIs) are a significant concern in febrile infants presenting within 24 hours post-immunization.
- Consider urine testing for febrile infants presenting within 24 hours of vaccination; manage those presenting >24 hours post-vaccination similarly to unvaccinated infants.
Objective:
The objective of this study was to investigate the prevalence of serious bacterial infection (SBI) in febrile infants without a source aged 6-12 weeks who have received immunizations in the preceding 72 hours.
Methods:
The authors conducted a medical record review of infants aged 6-12 weeks with a fever of > or = 38.0 degrees C presenting to the pediatric emergency department (ED) over 88 months. Infants were classified either as having received immunizations within the 72 hours preceding the ED visit (recent immunization [RI]) or as not having received immunizations during this time period (no recent immunization [NRI]). Primary outcome of an SBI was based on culture results; only patients with a minimum of blood and urine cultures were studied.
Results:
A total of 1,978 febrile infants were studied, of whom 213 (10.8%) had received RIs. The overall prevalence of definite SBI was 6.6% (95% confidence interval [CI] = 5.5 to 7.7). The prevalence of definite SBI in NRI infants was 7.0% (95% CI = 5.9 to 8.3) compared to 2.8% (95% CI = 0.6 to 5.1) in the RI infants. The prevalence of definite SBI in febrile infants vaccinated in the preceding 24 hours decreased to 0.6% (95% CI = 0 to 1.9). The prevalence of definite SBI in febrile infants vaccinated greater than 24 hours prior to presentation was 8.9% (95 CI = 1.5 to 16.4). The relative risk of SBI with RI was 0.41 (95% CI = 0.19 to 0.90). All SBIs in the RI infants were urinary tract infections (UTI).
Conclusions:
Among febrile infants, the prevalence of SBI is less in the initial 24 hours following immunizations. However, there is still a substantial risk of UTI. Therefore, urine testing should be considered in febrile infants who present within 24 hours of immunization. Infants who present greater than 24 hours after immunizations with fever should be managed similarly to infants without RIs.
Related Concept Videos
Bacterial Meningitis I: Introduction
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Bacterial Meningitis
Vaccinations
Viral Meningitis
Bacterial Meningitis II: Pathophysiology
